FDA DEVICE FACTS
VersaPAP Positive Airway Pressure (PAP) Device
Trudell Medical International
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
VersaPAP™ is indicated for the treatment and prevention of atelectasis. VersaPAP™ also has the ability to provide supplemental oxygen when used with compressed oxygen. The VersaPAP™ device is for patients (ages 5 years and above) who are capable of following directions for Positive Airway Pressure Therapy in a hospital environment. The VersaPAP™ device is a single patient, multiple use device intended to be used under the supervision of a healthcare professional.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。